| Bt Health | |
|
1580 Valencia St Ste 201 San Francisco CA 94110-4420 | |
| (415) 550-0811 | |
| Not Available |
| Full Name | Bt Health |
|---|---|
| Speciality | Internal Medicine |
| Location | 1580 Valencia St Ste 201, San Francisco, California |
| Authorized Official Name and Position | Tricia Nguyen (CHIEF MEDICAL OFFICER) |
| Authorized Official Contact | 5106074000 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bt Health 20 Skyview Ter San Rafael CA 94903-1825 Ph: (415) 785-4246 | Bt Health 1580 Valencia St Ste 201 San Francisco CA 94110-4420 Ph: (415) 550-0811 |
| NPI Number | 1265719033 |
|---|---|
| Provider Enumeration Date | 11/08/2011 |
| Last Update Date | 01/08/2024 |
| Medicare PECOS PAC ID | 4385808617 |
|---|---|
| Medicare Enrollment ID | O20120615000576 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265719033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Therese Rose Grenchik |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679608442 PECOS PAC ID: 2365417979 Enrollment ID: I20040827000597 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Kris C Kealey |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1144243361 PECOS PAC ID: 4880610294 Enrollment ID: I20051014000611 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Yvette M Gentry |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1467498634 PECOS PAC ID: 7214933704 Enrollment ID: I20061005000388 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Mark E Higgins |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134193469 PECOS PAC ID: 5395837850 Enrollment ID: I20070828001066 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Kathryn J Drinkard |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487740437 PECOS PAC ID: 3072601707 Enrollment ID: I20071114000248 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Suzanne Christina Bodor-billings |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356491724 PECOS PAC ID: 1052409794 Enrollment ID: I20071114000271 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Julie A Omelveny |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1861579609 PECOS PAC ID: 2365530094 Enrollment ID: I20071114000281 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Carolyn B Klebanoff |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1093892846 PECOS PAC ID: 1456449180 Enrollment ID: I20071114000308 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Ann S Omachi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780743740 PECOS PAC ID: 3072684869 Enrollment ID: I20080623000329 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Barbara M Bishop |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1144302126 PECOS PAC ID: 9234125857 Enrollment ID: I20080630000734 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Jesse H Dohemann |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396857462 PECOS PAC ID: 2769550987 Enrollment ID: I20081001000308 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Virginia I Cafaro |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1174596969 PECOS PAC ID: 0042307241 Enrollment ID: I20081028000517 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Gary B Birnbaum |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1972685972 PECOS PAC ID: 6507928926 Enrollment ID: I20081218000762 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Marilyn Milkman |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1477515203 PECOS PAC ID: 3870676976 Enrollment ID: I20090202000186 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Sacha Zuleika Niemi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1154359982 PECOS PAC ID: 5092708339 Enrollment ID: I20091121000082 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Monita S Yuen-green |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1013000868 PECOS PAC ID: 3476698168 Enrollment ID: I20100305000336 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Karen Khoo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1629031430 PECOS PAC ID: 3072645654 Enrollment ID: I20100716000613 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Leah Tessler |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1437111275 PECOS PAC ID: 5991886608 Enrollment ID: I20101201001172 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Stephen Knox |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1255439345 PECOS PAC ID: 0345424958 Enrollment ID: I20110406000247 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Gerald A Hom |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1417035023 PECOS PAC ID: 4880879410 Enrollment ID: I20110426000498 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Alfred M Lerner |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1447337399 PECOS PAC ID: 1456573120 Enrollment ID: I20141112002458 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Debbie L Brachman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851727275 PECOS PAC ID: 4486879053 Enrollment ID: I20150417001512 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Namui Choi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295123727 PECOS PAC ID: 6800103680 Enrollment ID: I20151214002576 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Naomi Anne Hetzel |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457996936 PECOS PAC ID: 9537593017 Enrollment ID: I20191217001902 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Dinna Getachew |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1144715020 PECOS PAC ID: 1658614565 Enrollment ID: I20210909001561 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Jason Wertheimer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1154855922 PECOS PAC ID: 8729359021 Enrollment ID: I20210922003481 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Amanda Massad |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467940825 PECOS PAC ID: 6800226960 Enrollment ID: I20211001002175 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Sumatt Kamal |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639666563 PECOS PAC ID: 6800143405 Enrollment ID: I20211208002613 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Jessica Kung |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790438075 PECOS PAC ID: 2860886413 Enrollment ID: I20220225000528 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Necole Dugan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386147916 PECOS PAC ID: 1557757671 Enrollment ID: I20220329002118 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Shan-yu Hoekman |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1114274339 PECOS PAC ID: 5890001309 Enrollment ID: I20220406001740 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Deirdre Grace Power |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902493117 PECOS PAC ID: 4880080324 Enrollment ID: I20220408000971 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Dirk M Collevecchio |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467931360 PECOS PAC ID: 2163750233 Enrollment ID: I20220519000005 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Jenna Keohane |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235675901 PECOS PAC ID: 1951685106 Enrollment ID: I20220914000968 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Tara Jean Reilly |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710905104 PECOS PAC ID: 0648550244 Enrollment ID: I20221129002883 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
| Provider Name | Savanna Danielle Kirk |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588379168 PECOS PAC ID: 7618331125 Enrollment ID: I20230918001728 |
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
News Archive
Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.
Up to two million lives, annually, could be saved globally with improvements in trauma care, particularly in low- and middle-income countries. This estimate by Charles Mock, from the University of Washington in Seattle, and his team provides support for investment in and greater attention to strengthening trauma care services globally. Their work is published online in Springer's World Journal of Surgery.
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack.
› Verified 7 days ago
Richard Joseph Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 548 Market St # 50727, San Francisco, CA 94104 Phone: 415-851-3224 | |
James Y.greenberg, Md, A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2299 Post St Ste 205, San Francisco, CA 94115 Phone: 415-474-7955 Fax: 415-292-0718 | |
Inpatient Services Of California, Inc., A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3555 Cesar Chavez St, San Francisco, CA 94110 Phone: 415-641-6401 | |
Jew & Jew Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 919 Clay St, San Francisco, CA 94108 Phone: 415-982-4011 Fax: 415-982-6291 | |
Hampton Health Ltd Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1700 California St, Ste. 470, San Francisco, CA 94109 Phone: 415-202-9990 Fax: 415-843-0548 | |
North East Medical Services-leland Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 82 Leland Avenue, San Francisco, CA 94134 Phone: 415-391-9686 Fax: 415-333-9067 | |
Mission Area Health Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1580 Valencia St Ste 506, San Francisco, CA 94110 Phone: 415-852-4080 Fax: 415-431-3178 |